We are live on ! Find out more
CKPT

Checkpoint Therapeutics
CKPT

Delisted

CKPT was delisted on the 29th of May, 2025.

Back to rankings

40 hedge funds and large institutions have $16.6M invested in Checkpoint Therapeutics in 2019 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 10 increasing their positions, 5 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 6

100% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 5

85% more capital invested

Capital invested by funds: $8.96M → $16.6M (+$7.63M)

82% more funds holding

Funds holding: 22 → 40 (+18)

0.83% more ownership

Funds ownership: 1.08% → 1.91% (+0.83%)

Holders
40
Holders Change
+18
Holders Change %
+81.82%
% of All Funds
0.87%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
24
Increased
10
Reduced
5
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$4.61M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$2.57M
3
State Street
State Street
Massachusetts
+$1.09M
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$943K
5
N
Nuveen
North Carolina
+$248K

Top Sellers

Rank Fund Capital Flow
1
FWM
Frontier Wealth Management
Missouri
-$603K
2
PAS
Park Avenue Securities
New York
-$199K
3
SKK
Shepherd Kaplan Krochuk
Massachusetts
-$157K
4
FAM
Fenimore Asset Management
New York
-$108K
5
ECM
ExodusPoint Capital Management
New York
-$101K
Name Holding Trade Value Shares
Change 		Change in
Stake
BlackRock
1
BlackRock
New York
$8.51M +$4.61M +117,407 +72%
Vanguard Group
2
Vanguard Group
Pennsylvania
$3.68M +$2.57M +65,583 +118%
Geode Capital Management
3
Geode Capital Management
Massachusetts
$900K +$943K +24,019 +422%
State Street
4
State Street
Massachusetts
$547K +$1.09M +27,736 New
Renaissance Technologies
5
Renaissance Technologies
New York
$426K +$64K +1,630 +13%
OPPM
6
Opus Point Partners Management
New York
$342K – – –
N
7
Nuveen
North Carolina
$191K +$248K +6,319 New
Northern Trust
8
Northern Trust
Illinois
$185K +$76.1K +1,938 +47%
Bank of New York Mellon
9
Bank of New York Mellon
New York
$181K +$149K +3,784 +175%
Royal Bank of Canada
10
Royal Bank of Canada
Ontario, Canada
$166K -$46K -1,171 -18%
Charles Schwab
11
Charles Schwab
California
$146K +$123K +3,139 +189%
Millennium Management
12
Millennium Management
New York
$124K +$161K +4,091 New
Deutsche Bank
13
Deutsche Bank
Germany
$120K +$157K +3,992 New
California State Teachers Retirement System (CalSTRS)
14
California State Teachers Retirement System (CalSTRS)
California
$108K +$139K +3,549 New
FAM
15
Fenimore Asset Management
New York
$98K -$108K -2,760 -46%
Susquehanna International Group
16
Susquehanna International Group
Pennsylvania
$96K +$124K +3,155 New
Jane Street
17
Jane Street
New York
$95K +$124K +3,152 New
New York State Common Retirement Fund
18
New York State Common Retirement Fund
New York
$93K +$121K +3,080 New
Acadian Asset Management
19
Acadian Asset Management
Massachusetts
$84K +$109K +2,771 New
RhumbLine Advisers
20
RhumbLine Advisers
Massachusetts
$51K +$66.2K +1,686 New
VOYA Investment Management
21
VOYA Investment Management
Georgia
$51K +$66.2K +1,686 New
VF
22
Virtu Financial
New York
$49K +$63K +1,606 New
AIG
23
American International Group
New York
$45K +$57.5K +1,466 New
Barclays
24
Barclays
United Kingdom
$45K +$58.3K +1,486 New
ARTA
25
A.R.T. Advisors
New York
$45K +$58.6K +1,492 New
1
2

CKPT Hedge Fund Activity: Q2 2019 in Review

40 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in Checkpoint Therapeutics (CKPT) for Q2 2019, worth a combined $16.6M — up 85% from $8.96M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new CKPT positions and 6 closed out — a net gain of 18 holders — while 10 added to existing stakes and 5 trimmed.

The largest buyer was BlackRock, adding an estimated $4.61M. The largest seller was Frontier Wealth Management, exiting entirely with an estimated $603K sold.

  • 40 institutional investors held Checkpoint Therapeutics (CKPT) as of Q2 2019, up from 22 in Q1 2019.
  • Funds reported $16.6M of Checkpoint Therapeutics stock for Q2 2019, up 85% quarter-over-quarter.
  • 24 funds opened new Checkpoint Therapeutics positions in Q2 2019 and 6 closed out, a net change of +18 holders.
  • The largest Checkpoint Therapeutics buyer in Q2 2019 was BlackRock, an estimated $4.61M added.
  • The largest Checkpoint Therapeutics seller in Q2 2019 was Frontier Wealth Management, an estimated $603K sold.

Based on aggregated 13F filings for Q2 2019.